Anterix Inc. Fundamental Analysis
Anterix Inc. (ATEX) shows moderate financial fundamentals with a PE ratio of 17.98, profit margin of 13.94%, and ROE of 39.26%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 75.9/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze ATEX's fundamental strength across five key dimensions:
Efficiency Score
ExcellentATEX demonstrates superior asset utilization.
Valuation Score
ExcellentATEX trades at attractive valuation levels.
Growth Score
WeakATEX faces weak or negative growth trends.
Financial Health Score
ExcellentATEX maintains a strong and stable balance sheet.
Profitability Score
ModerateATEX maintains healthy but balanced margins.
Key Financial Metrics
Is ATEX Expensive or Cheap?
P/E Ratio
ATEX trades at 17.98 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, ATEX's PEG of 0.01 indicates potential undervaluation.
Price to Book
The market values Anterix Inc. at 6.24 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at -167.76 times EBITDA. This is generally considered low.
How Well Does ATEX Make Money?
Net Profit Margin
For every $100 in sales, Anterix Inc. keeps $13.94 as profit after all expenses.
Operating Margin
Core operations generate 14.45 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $39.26 in profit for every $100 of shareholder equity.
ROA
Anterix Inc. generates $19.48 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Anterix Inc. generates strong operating cash flow of $5.56M, reflecting robust business health.
Free Cash Flow
Anterix Inc. generates strong free cash flow of $5.52M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.29 in free cash annually.
FCF Yield
ATEX converts 0.33% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
17.98
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.01
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.24
vs 25 benchmark
P/S Ratio
Price to sales ratio
253.76
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.02
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.33
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.39
vs 25 benchmark
ROA
Return on assets percentage
0.19
vs 25 benchmark
ROCE
Return on capital employed
0.22
vs 25 benchmark
How ATEX Stacks Against Its Sector Peers
| Metric | ATEX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 17.98 | 18.26 | Neutral |
| ROE | 39.26% | 453.00% | Weak |
| Net Margin | 1394.17% | -301.00% (disorted) | Strong |
| Debt/Equity | 0.02 | 0.73 | Strong (Low Leverage) |
| Current Ratio | 3.33 | 1.98 | Strong Liquidity |
| ROA | 19.48% | -37.00% (disorted) | Strong |
ATEX outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Anterix Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Growth, Technology, Streaming
EPS CAGR
N/A
Industry Style: Growth, Technology, Streaming
FCF CAGR
N/A
Industry Style: Growth, Technology, Streaming